HAEMONETICS CORP — Director's Dealing 2016

Aug 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2016-07-29

Reporting Person: GELBMAN RONALD G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-29	Common Stock	F	11614	$30.09	Disposed	55371	Direct
2016-07-29	Common Stock	M	11758	$29.72	Acquired	66985	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-29	Non-qualified Stock Option (Right to Buy)	$29.72	M	11758	Disposed	2016-07-30	Common Stock (11758)	Direct

Footnotes

F1: Grant to reporting person of right to buy shares of common stock exercisable 100 percent on the first anniversary of the date of grant.